SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)

2/14/24 3:53:17 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $REPH alert in real time by email

SC 13G/A 1 Societal13g123123t.txt SCTL 13G/A THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Societal CDMO, Inc. (Formally Recro Pharma, Inc.) (Name of Issuer) Common Stock, Par Value $0.001 (Title of Class of Securities) 75629F109 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person?s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 75629F109 (1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons (entities only): AWM Investment Company, Inc. (2) Check the Appropriate Box if a Member of a Group (See Instructions) (a)___ b)___ (3) SEC Use Only (4) Citizenship or Place of Organization: Delaware, United States Number of Shares Beneficially Owned by Each Reporting Person With (5) Sole Voting Power: 7,226,414** Common Shares 10,468,341(9.99% of outstanding shares)** (6) Shared Voting Power: 0** (7) Sole Dispositive Power: 7,226,414** Common Shares 10,468,341(9.99% of outstanding shares)** (8) Shared Dispositive Power: 0** (9) Aggregate Amount Beneficially Owned by Each Reporting Person: 7,226,414**Common Shares, 10,468,341(9.99% of outstanding shares)** (10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions): (11) Percent of Class Represented by Amount in Row (9): 9.99%** (12) Type of Reporting Person (See Instructions): IA **AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Cayman Fund, L.P. (CAYMAN), Special Situations Fund III QP, L.P. (SSFQP) and Special Situations Private Equity Fund, L.P. (SSPE). (CAYMAN, SSFQP and SSPE will hereafter be referred to as the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 1,445,202 shares of Common Stock of the Issuer (the Shares) and 873,569 Warrants*** to purchase shares held by CAYMAN, 4,194,731 Shares, 3,365,985 Warrants*** to purchase shares held by SSFQP, 1,586,481 Shares and 620,446 Warrants*** to purchase shares held by SSPE. See Items 2 and 4 of this Schedule for additional information. *** Warrants described herein may only be exercised into Common Shares to the extent that the total number of Common Shares then beneficially owned does not exceed 9.99% of the outstanding shares. Item 1(a). Name Of Issuer: Societal CDMO, Inc. (Formally Recro Pharma, Inc.) Item 1(b). Address of Issuer?s Principal Executive Offices: 1 E. Uwchlan Avenue, Suite 112 Exton, Pennsylvania 19341 Item 2(a). Name of Person Filing: The person filing this report is AWM Investment Company, Inc., a Delaware corporation (AWM), which is the investment adviser to Special Situations Cayman Fund, L.P., a Cayman Islands Limited Partnership (CAYMAN), Special Situations Fund III QP, L.P., a Delaware limited partnership (SSFQP) and Special Situations Private Equity Fund, L.P., a Delaware limited partnership (SSPE), (CAYMAN, SSFQP and SSPE, will hereafter be referred to as the Funds). The principal business of each Fund is to invest in equity and equity-related securities and other securities of any kind or nature. David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are members of: SSCayman, L.L.C., a Delaware limited liability company (SSCAY), the general partner of CAYMAN. Greenhouse and Stettner are members of MGP Advisers Limited Partnership, a Delaware limited partnership (MGP), the general partner of SSFQP; MG Advisers, L.L.C., a New York limited liability company (MG), the general partner of SSPE. Greenhouse and Stettner are also controlling principals of AWM. Item 2(b). Address of Principal Business Office or, if None, Residence: The principal business address for AWM is c/o Special Situations Funds, 527 Madison Avenue, Suite 2600, New York, NY 10022. Item 2(c). Citizenship: AWM is a Delaware Corporation. Item 2(d). Title of Class of Securities: Common Stock, Par Value $0.001 Item 2(e). CUSIP No.: 75629F109 Item 3. If This Statement Is Filed Pursuant to ??240.13d-1(b) or 240.13d-2(b) or (c), check whether the Person Filing is a: Not Applicable. Item 4. Ownership (a) Amount Beneficially Owned 7,226,414** Common Shares 10,468,341(9.99% of outstanding shares)** (b) Percent of Class: 9.99%** (c) Number of Shares as to which the person has: (i) sole power to vote or to direct the vote: 7,226,414** Common Shares 10,468,341 (9.99% of outstanding Shares)** (ii) shared power to vote or to direct the vote: 0** (iii) sole power to dispose or to direct the disposition of: 7,226,414** Common Shares 10,468,341 (9.99% of outstanding shares)** (iv) shared power to dispose or to direct the disposition of: 0** ______________________________________________________________________ ** AWM is the investment adviser to each of the Funds. As the investment adviser to the Funds, AWM holds sole voting and investment power over 1,445,202 shares of Common Stock of the Issuer (the Shares) and 873,569 Warrants*** to purchase shares held by CAYMAN, 4,194,731 Shares, 3,365,985 Warrants*** to purchase shares held by SSFQP, 1,586,481 Shares and 620,446 Warrants*** to purchase shares held by SSPE. Greenhouse and Stettner are members of: SSCAY, the general partner of CAYMAN; MGP, the general partner of SSFQP; and MG, the general partner of SSPE. Greenhouse and Stettner are also controlling principals of AWM. Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ___ Item 6. Ownership of More Than Five Percent on Behalf of Another Person Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person Not Applicable. Item 8. Identification and Classification of Members of the Group Not Applicable. Item 9. Notice of Dissolution of Group Not Applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 13, 2024 AWM INVESTMENT COMPANY, INC. By: /s/ Adam Stettner___ Name: Adam Stettner Title: Executive Vice President Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) -1-

Get the next $REPH alert in real time by email

SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)

Chat with this insight

Recent Analyst Ratings for
$REPH

$REPH
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Lake Ryan David covered exercise/tax liability with 1,022 shares, decreasing direct ownership by 0.13% to 800,557 units (SEC Form 4)

Enloe J David Jr was granted 196,474 shares, increasing direct ownership by 18% to 1,295,414 units (SEC Form 4)

Lake Ryan David was granted 110,025 shares and covered exercise/tax liability with 37,453 shares, increasing direct ownership by 10% to 801,579 units (SEC Form 4)

$REPH
Financials

Live finance-specific insights

Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022

Recro Reports Third Quarter 2021 Financial Results

Recro to Report Financial Results for Third Quarter 2021 on November 9, 2021

$REPH
Press Releases

Fastest customizable press release news feed in the world

Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation

Recro Reports Fourth Quarter and Year End 2021 Financial Results

Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facility

$REPH
Large Ownership Changes

This live feed shows all institutional transactions in real time.